跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 425 条关于
“ABL1”
全部
425
临床试验
303
药物
55
机构
3
资讯
64
去年
Non-ABL1 Mutations Impact Outcomes in Chronic Myeloid Leukemia
6个月前
Digital PCR Outperforms Standard RT-qPCR in Detecting Residual BCR::ABL1 in CML Patients, Enabling Better TKI Discontinuation Decisions
3年前
Asciminib Demonstrates Durable Efficacy and Safety in Heavily Pretreated CML-CP Patients
去年
ABL Bio and MSD Collaborate to Evaluate ABL103 with Keytruda in Solid Tumors
去年
Novartis Receives CDSCO Approval for Phase IIIb Trial of Asciminib in Chronic Myeloid Leukemia
去年
FDA Approves Scemblix (asciminib) for First-Line Treatment of Chronic Myelogenous Leukemia
8个月前
ABL Bio Secures $55 Million from Eli Lilly for Grabody Bispecific Antibody Platform Development
去年
Enliven Therapeutics' ELVN-001 Shows Promising Phase 1 Data in Chronic Myeloid Leukemia
去年
ABL Bio Receives Regulatory Approval for Triple Combination Cancer Therapy Trial
5个月前
Flumatinib Therapeutic Drug Monitoring Reveals Key Exposure Thresholds for Molecular Response in Chinese CML-CP Patients
第 1 页,共 7 页
上一页
下一页